Annual Congress Glasgow 2004

Saturday, 04.09.2004
Sunday, 05.09.2004
Monday, 06.09.2004
Tuesday, 07.09.2004
Wednesday, 08.09.2004

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 24: Suppl. 48, abstract number.


Material from 2004:
  • 3888 Abstracts
  • 555 Slide presentations
  • 20 Webcasts
  • 96 Handouts
Material from 2004:  Show

Acute exacerbations and drug therapy in COPD

Oral Presentation
Chairs: C. Vogelmeier (Marburg, Germany), P. Weiner (Hadera, Israel)
Influence of expiratory flow limitation in COPD on regional lung deposition
H. Burkard, P. Haidl, P. Appelhans, F. Gessenhardt, D. Köhler (Schmallenberg, Germany)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
The use of intravenous aminophylline in treatment of exacerbations of COPD
N. Duffy, F. Diamantea, P. Walker, P. Calverley, L. Davies (Liverpool, United Kingdom)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
The effects of uncontrolled oxygen therapy in the ambulance on outcome of patients admitted with exacerbation of chronic obstructive pulmonary disease (COPD)
R. V. Reddy, M. Iqbal, A. Yeung, K. S. Srinivasan, C. F. A. Pantin (Stoke on Trent, United Kingdom)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Variation in the care of hospitalized acute exacerbations of COPD between generalists and pulmonologists
K. M. Sanders, T. K. Marras, J. Yang, A. Shawn, C. K. N. Chan, M. S. Balter (Toronto, Ottawa, Canada)
Congress or journal article abstract
Congress or journal article abstract
Bronchoalveolar lavage in COPD, smokers and non-smokers: inflammatory cells and macrophage phenotype
M. J. Löfdahl, A. Eklund, J. Grunewald, M. C. Sköld (Stockholm, Sweden)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD
L. Lehtimäki, H. Kankaanranta, I. Annila, T. Aine, S. Saarelainen, H. Lehtonen, J. Laitinen, R. Järvenpää, A. Lahdensuo, E. Moilanen (Tampere, Finland)
Congress or journal article abstract
Congress or journal article abstract
Glucocorticosteroid reversibility testing with oral prednisone (²steroid trial²) for 4 weeks: time-response study using serial spirometry and 6-minute walk distance (6MWD) in patients with moderate to severe stable COPD
M. M. Schuurmans, P. R. Botha, D. Steyn, D. Richter, C. T. Bolliger (Tygerberg, South Africa)
Congress or journal article abstract
Congress or journal article abstract
Misdiagnosis of COPD in primary care
D. G. Tinkelman, D. Price, R. J. Nordyke, S. Isonaka, R. J. Halbert (Denver, Beverly Hills, United States Of America; Aberdeen, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract